Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for GI Dysfunction in Children Following HCT
NCT05664113Phase 1Recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Jul 2025
- Primary completion
- Dec 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label trial of Fecal Microbiota Transplantation capsules in graft-versus-host disease (GVHD) and Digestive tract dysfunction (2 arms), sponsored by St. Jude Children's Research Hospital. Primary endpoints: Serious Adverse Events at 30 days, Non-serious Adverse Events at 30 days and 4 more. Started Jul 2025; status: recruiting.
02
Drugs
Fecal Microbiota Transplantation capsules
03
Conditions
graft-versus-host disease (GVHD)Digestive tract dysfunction
Beyond the preview
Go deeper on NCT05664113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05664113.